|
2
|
|
Perturbation of cellular response pathway, leading to adverse effects,
|
|
8
|
|
3
|
|
DNA sequencing output,
|
|
11
|
|
4
|
|
Throughput potential for data acquisition as related to levels of biologic organization,
|
|
13
|
|
5
|
|
Illustration of bioactivity profiling using high-throughput technologies to screen chemicals,
|
|
14
|
|
6
|
|
Overview of chemical registration for REACH,
|
|
21
|
|
7
|
|
Integration of new approaches for toxicology,
|
|
22
|
|
8
|
|
Dosimetry considerations in cell systems,
|
|
28
|
|
9
|
|
What do cells see? Protein adsorption by nanomaterials is a universal phenomenon in biologic systems,
|
|
28
|
|
10
|
|
Example of gene ontology for DNA metabolism, a biologic process,
|
|
31
|
|
11
|
|
Framework for interpretation of dose- and time-dependent genomic data,
|
|
32
|
|
12
|
|
Integrated data provide more comprehensive and accurate network reconstruction,
|
|
36
|
|
13
|
|
Illustration of the development of modular network models,
|
|
37
|
|
14
|
|
Interaction network that can be used to associate environmental factors with toxicity pathways and associated human diseases,
|
|
43
|